Navigation Links
Covance Central Laboratory Services Again Ranks #1 in Global Investigator Satisfaction Survey
Date:7/29/2013

PRINCETON, N.J., July 29, 2013 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that its central laboratory services once again ranked first in an independent global survey of physician investigators participating in clinical trials.  Forty-seven percent of the study participants named Covance's central laboratory services as their "most preferred" central laboratory, with investigators citing Covance more than twice as often as the nearest competitor.  Investigators also reported having the "best overall relationship" with Covance, rating it 8.4 on a scale of 1 to 10.

Survey results underscore the growing importance of the selection of a preferred central laboratory because of its direct connection to investigators' satisfaction and their willingness to work with sponsors in the future.  In addition, most physicians who want to learn about being a clinical trial investigator talk first to other doctors involved in clinical trials.

"This study demonstrates that investigators around the world continue to recognize and value Covance's services and benefit from our decades of experience and extensive testing capabilities," said Jon Koch, Corporate Vice President and Global General Manager, Central Laboratory Services.  "Our ability to deliver central laboratory services on target and on time, coupled with our commitment to meeting the evolving needs of clients and investigators, is what makes Covance a leader in providing drug development services and helps our clients bring medicines to market faster."

The report shows a clear link between overall investigator satisfaction and sponsors' choice of central laboratory, with 100 percent of respondents reporting they were satisfied when pharmaceutical sponsors select the investigators' preferred central laboratory.  W
'/>"/>

SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Covance To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
2. Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
3. Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients Increased Asia Pacific Focus
4. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2013 Financial Results Conference Call
5. Covance To Present At The Citi 2013 Global Healthcare Conference
6. Covance To Present At The Leerink Swann Global Healthcare Conference
7. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
8. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
9. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
10. Covance to Present at the Morgan Stanley Global Healthcare Conference
11. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market ... is an autoimmune disease that permanently destroys beta cells of ... longer produce insulin. Over the last 90 years, insulin therapy ... can be offered to a patient who is newly diagnosed ... of action - long-acting as well as short or rapid-acting ...
(Date:5/27/2015)... 27, 2015 PharmaPoint: Systemic Lupus Erythematosus and ... to 2022 - Event-Driven Update Summary ... GlaxoSmithKline,s Benlysta is the only drug that has gained ... Following Benlysta,s launch, patients, uptake has remained low, but ... to grow the lupus market in terms of value ...
(Date:5/27/2015)... , May 27, 2015 ... http://www.researchandmarkets.com/research/bnrjw5/2015_strategies ) has announced the addition of ... Acid Testing Market"  report to their ... , ,Major issues pertaining to the US ... economic, regulatory, demographic, social and technological trends ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3United States Nucleic Acid Testing Market Strategies 2015-2020 2
(Date:5/27/2015)... (PRWEB) May 28, 2015 Throughout the past ... site for research comparing the validity and reliability of the ... Preeti Nair, P.T., Ph.D., Associate Professor in the Department of ... for the study. , The Shaw Gait Assessment is a ... of equipment. The GaitRite is considered the gold standard ...
(Date:5/27/2015)... StatRad, a leading provider of cloud-based ... introduce Mr. Chris E. Hafey as its new Chief ... record of leading new development projects and has extensive ... recently served as the Chief Technology Officer for OnPoint ... Architect for Vital Images. , "I am very excited ...
(Date:5/27/2015)... Khanna Vision Institute (KVI) announced the launch ... on keratoconus eye disease . Keratoconus is commonly known ... onset in the teenage years. It worsens over the next ... clear part of the eye is defective. It becomes thin ... results in poor vision which cannot even be corrected with ...
(Date:5/27/2015)... Arizona (PRWEB) May 27, 2015 Continuing ... mission of healthier patients in the community, SmartPractice® ... Center (formerly John C. Lincoln). SmartPractice Vice President of ... Michelle Shaw presented a $25,000 check to Paulla Miller, ... HonorHealth’s Breast Health & Research Center on April 30. ...
(Date:5/27/2015)... CT (PRWEB) May 27, 2015 Dr. ... Institute based in Stamford, CT has been selected as ... the first physicians nationwide (and the only physician in ... injectable which allows for the removal of submental fat ... to no recovery time, no surgery and minimal risks. ...
Breaking Medicine News(10 mins):Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3
... network of collaborative research. Building on a tool that was ... of Brain , Dr. Yaniv Assaf of Tel Aviv ... of scientists to understand how different parts of the human ... "brain atlas." Brain researchers already know that autism and ...
... as young as four weeks old are being fed a ... new Australian research. A study published in the journal ... been introduced to high fat, salt and sugar foods, despite ... Researcher Jane Scott and colleagues tracked 587 women ...
... Gardner HealthDay Reporter , MONDAY, Sept. 6 ... and proteins from vegetable sources rather than meats is ... types of diets over two decades, researchers found that ... death from cardiovascular disease and cancer, and a lower ...
... About 17 percent of all visits to hospital emergency ... retail medical clinics or urgent care centers, potentially saving ... a new RAND Corporation study. Conditions that could ... fractures and lacerations, according to findings published in the ...
... of California, San Diego School of Medicine have shown ... examining dynamic geometric patterns than they do looking at ... either typical or developmentally delayed toddlers. The results ... patterns early in life may be a signature behavior ...
... a combination of medication and a psychosocial intervention appear ... improved insight, quality of life and social functioningthan those ... September issue of Archives of General Psychiatry , ... the mainstay of therapy for patients with schizophrenia, but ...
Cached Medicine News:Health News:Mapping a brain atlas 2Health News:What are babies made of? Research shows for some it is sugar, salt and not all things nice 2Health News:Low-Carb Diets Heavy on Meat May Raise Health Risks 2Health News:Many hospital emergency department visits could be treated elsewhere, study finds 2Health News:Many hospital emergency department visits could be treated elsewhere, study finds 3Health News:Visual pattern preference may be indicator of autism in toddlers 2Health News:Visual pattern preference may be indicator of autism in toddlers 3Health News:Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia 2
... Experience the finest surgical-quality loupes ... set the standard for innovative optical ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. Make ...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... optimum performance with maximum comfort, SheerVision ... medical professionals worldwide. Make both a ...
... SheerVision manufactures its signature line of award-winning ... Frame. These next generation loupes feature ... design, and are multi-coated lens for anti-glare, ... SV Sport frame offers a stylish, yet ...
... FireFly LED light offers superior illumination in ... FireFly LED you'll get powerful, long-lasting illumination ... practice demands. High center-beam brightness and hands-free ... while the rechargeable battery provides over five ...
Medicine Products: